B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor [Phase 1]
This clinical trial update notes a Phase 1 study of the investigational therapy HDM2005 in patients with relapsed or refractory B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating Zydelig (idelalisib) as maintenance therapy after autologous stem cell transplantation in B-cell non-Hodgkin lympho…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases [Phase 1]
This clinical trial update outlines the Phase 1 study JWCAR201 for hematology malignancies and autoimmune diseases, which is currently not r…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies [Phase 2]
This update announces the completion of a Phase 2 trial evaluating CD19-CAR-T2 cells for CD19-positive B-cell malignancies, including B-cell…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL [Phase 1, Phase 2]
Mustang Bio's MB-106 study in relapsed or refractory B-cell lymphomas and chronic lymphocytic leukemia has been terminated, covering Phase 1…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
A cohort-study analysis evaluating the incidence and risk factors of CMV reactivation in patients receiving CAR-T cell therapy for relapse o…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) [Phase 2]
Phase 2 clinical trial update on LOXO-305 (pirtobrutinib) in Chinese participants with B-cell malignancies, with results posted on July 16, …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies [Phase 1]
Phase 1 study of STRO-001, an anti-CD74 antibody-drug conjugate, in advanced B-cell malignancies has been completed.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma [Phase 1]
Phase 1 clinical trial evaluating ISM8207 in participants with advanced solid tumors or relapsed/refractory B-cell lymphoma, currently recru…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL [Phase 1]
Phase 1 study of CD19/CD22 CAR-T cells in adults with relapsed or refractory acute lymphoblastic leukemia or B-cell lymphoma, currently recr…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy [Phase 1]
Phase 1 clinical trial update for C-CAR066 in relapsed/refractory B-cell lymphoma patients who previously received CD19 CAR-T therapy.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy [NA]
A completed clinical trial evaluating the feasibility of a digital health coaching program for individuals after CAR T-cell therapy.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating obinutuzumab in combination with bendamustine for mature B-cell lymphoma; currently recruiting in China.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CAR20(NAP)-T therapy for B-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma [Phase 1]
Phase 1 study evaluating safety and efficacy of Glofitamab or Mosunetuzumab with gemcitabine plus oxaliplatin in relapsed/refractory B-cell …
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study of MIL62 Combined With Orelabrutinib for the Treatment of R/R CD20+B Cell Lymphoma [Phase 1, Phase 2]
A clinical trial update for MIL62 combined with Orelabrutinib in relapsed/refractory B-cell lymphoma (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CAR-T cells targeting CD19 and CD22 for relapsed or refractory B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Allo HSCT Using RIC for Hematological Diseases [Phase 2]
Phase 2 trial evaluating allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for various hematologic dise…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL [Phase 1, Phase 2]
Clinical trial update for tazemetostat as a single agent and in combination in B-cell lymphomas and solid tumors completed with results post…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating a novel anti-CD19 CAR-T therapy in patients with relapsed/refractory B-cell malignancies (leukemia and lymphoma).
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating CAR-T therapy targeting CD19 and CD22 for relapsed/refractory B-cell leukemia and lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma [Phase 1, Phase 2]
Clinical trial update for a CD19 and CD22 targeted PRIME CAR-T cell therapy in relapsed/refractory B cell lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating autologous stem cell transplantation combined with anti-CD19 CAR T cells for B-cell lymphoma is underway…
-
EMA withdrawal · 2023-02-10EMA Application withdrawn: Aliqopa (copanlisib dihydrochloride) — Bayer AG
The EMA has withdrawn the application for Aliqopa (copanlisib dihydrochloride) by Bayer AG for its use in lymphoma subtypes including margin…
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update on ublituximab for relapsed or refractory B-cell non-Hodgkin lymphoma completed phases 1 and 2.